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Abstract
Introduction. Adiponectin is an adipose tissue-derived adipocytokine protein, while leptin is the protein that maintains 
the body weight in humans via its effect on the hypothalamus. These hormones interact at different levels of cardio-
-metabolic risk factors.
This study aimed to assess the serum levels of adiponectin and leptin in patients with ischaemic heart disease and 
subjected to coronary calcium scoring (CCS) and coronary angiography.
Material and methods. We included 59 patients with ischaemic heart disease and 20 healthy subjects served as a con-
trol in this study. The patients were assessed by electrocardiograph, echocardiograph, coronary angiogram and coronary 
computerised tomography (CCT) for the assessment of CCS. Serum levels of adiponectin and leptin were determined by 
using enzyme-linked immunosorbent assay (ELISA) technique.
Results. Coronary computed tomography (CT) investigation explored, that 30.5% of patients had positive calcium score 
and 67.8% of patients did not show evidence of coronary changes by CT angiograph. The patients had significantly high 
leptin and low adiponectin levels compared with healthy subjects. Serum leptin levels were significantly low in patients 
with positive CCS and angiogram, compared with those who had no abnormal CCT. Significant positive correlation be-
tween ejection fraction and serum leptin (r = 0.285, p < 0.05) and non-significant correlation with serum adiponectin 
were observed.
Conclusions. Serum leptin and adiponectin levels are useful determinants in patients with ischaemic heart disease, as 
high serum leptin levels are associated with negative coronary CT and positively correlated with left ventricular ejection 
fraction.
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Introduction
Adiponectin is an adipose tissue-derived adipocytokine 
protein. In the circulation, adiponectin is available as 
a low-molecular-weight trimer, medium-molecular-weight 
hexamer, and a high-molecular-weight multimer form [1], 
that has stronger anti-atherogenic effects than other types 
of adiponectin [2]. Adiponectin is an important mediator 
against the development of coronary atherosclerosis [3, 4] 
and a low adiponectin level is a risk factor for cardiova-
scular events [5]. Low level of adiponectin concentration 
is observed in patients with coronary artery disease [6], 
or its risk factors [7] and it is also independently associa-
ted with the development of coronary artery calcification 
(CAC) [8]. The anti-atherosclerotic effects of adiponectin 
are achieved through improving the endothelial function 
and repair by endothelial progenitor cells; inhibiting the 
neointimal formation by suppressing proliferation and 
migration of vascular smooth muscle cells [9, 10] and 
blocking inflammation and foam cell formation from 
macrophages [11].
Leptin is a protein that plays a role in maintaining the 
body weight in humans via its effect on the hypothalamus. 
Leptin is involved in the regulation of the myocardial blood 
flow via its effect upon the vasoreactivity of coronary blood 
vessels [12] in addition to the prothrombotic effect [13]. 
The literature review revealed conflicting results about the 
association of coronary artery disease with leptin. Some 
authors reported an association between leptin with incre-
ased risk of the incident CAD [14, 15], while others found 
no association [16]. Khafaji et al. [17] found, that serum 
leptin levels increased after myocardial infarction and may 
be predictors of the left ventricular ejection fraction and 
the degree of atherosclerosis. Martin et al. [18] found, that 
serum leptin levels increased in asymptomatic overweight-
-obese individuals and were independently associated with 
increased coronary calcium score in the presence of high 
C-reactive protein levels. This study aimed to assess the 
association between hormones (notably adiponectin and 
leptin) that play a role in controlling the energy homeostasis 
and coronary artery atherosclerosis assessed by different 
diagnostic modalities, including coronary calcium scoring 
and coronary angiography.
Material and methods
This study was conducted in the Department of Medicine, 
College of Medicine, Diyala University in Iraq. Each patient 
signed a consent form prior to the admission to the study. 
The study was conducted according to the ethical guidelines 
constructed by the Scientific Committee of the Institute, in 
which the treatment or using device should not be harmful 
to the patient and the patient is free to decline from the 
study or to refuse for study admission.
The authors recruited the patients from the Consultant 
Clinics at The General Teaching Hospital of the College of 
Medicine in Diyala, Iraq. The patients had a previous hi-
story of coronary artery disease (including old myocardial 
infarction, and stable angina pectoris), and newly diagno-
sed coronary artery disease presented with chest pain on 
exertion, breathlessness, palpitation, etc. The criteria of 
exclusion included patients with a history of secondary 
hypertension, diabetes mellitus, chronic liver diseases, 
renal disorders, autoimmune diseases and drug intake 
e.g. non-steroidal anti-inflammatory drugs.
This study included 59 patients (24 men and 35 wo-
men) with clinical symptoms of ischaemic heart disease 
(frequent chest pain, dyspnea and palpitation). Another 
20 healthy subjects served as a control were enrolled for 
determining the baseline levels of adiponectin and leptin 
and using these values as baseline data for the compari-
son with the values of patients. All healthy subjects had 
normal ECGs records without any evidence of ischaemic 
heart disease or arrhythmias, normal blood pressures 
(the systolic and diastolic blood pressures were less than 
140 and 80 mm Hg) and the fasting lipid profiles were 
within normal limits. Demographic data, medical history 
and treatment were obtained from each patient. Modifiable 
risk factors, events or complications, and current therapy 
were recorded. A person who reported smoking on admis-
sion was assigned as current smoker. The anthropometric 
measurements, including height (m), weight (kg), waist 
circumference (cm) and hip circumference were measured. 
The body mass index (BMI), waist/hip ratio waist/height ra-
tios were calculated. The cut-off values for cardiometabolic 
risk factors were: BMI ≥ 25 kg/m2, waist circumference 
≥ 102 cm and waist to height ratio > 0.5.
The blood pressure (mm Hg) was measured in sitting 
position, and the mean of three readings was taken. The 
difference between systolic and diastolic blood pressure 
represented the pulse pressure and the mean arterial 
blood pressure was equal to diastolic blood pressure 
+ 1/3 pulse pressure. Systolic and diastolic blood pressures 
if ≥ 140 and 90 mm Hg respectively were considered as 
high blood pressure, whether the patients were treated or 
not with antihypertensive drugs. Then each patient was 
assessed by the electrocardiograph, echocardiograph, 
coronary angiogram and coronary computed tomography 
(coronary CT) for assessing coronary artery calcium score. 
In respect to the medical ethics, coronary angiogram and 
CT were not done.
Peripheral venous blood samples were drawn immedia-
tely into tubes on the day of the admission, then the blood 
samples were centrifuged at 2500 rpm for 10 minutes, and 
the sera were separated for determination of fasting lipid 
profile, and adiponectin and liponectin.
The determinants of lipid profile included fasting serum 
total cholesterol (TC), triglycerides (TG) and high-density 
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lipoprotein-cholesterol (HDL-c). The LDL-c lipoprotein (low-
-density lipoprotein-cholesterol, LDL-c) is determined by 
using the equation: TC- (HDL-c + TG/5). The log of the ratio 
of the triglyceride to the high-density lipoprotein value is 
the atherogenic index. Cut-off values of fasting serum 
triglyceride if ≥ 150 mg/dL and high-density lipoprotein 
≤ 35 mg/dL (men) and 50 mg/dL (women) were considered 
as cardiometabolic risk factors.
Quantitative determination of serum adiponectin and 
leptin was determined by using the enzyme-linked immu-
nosorbent assay (ELISA) technique. The principles of these 
tests are these substances reacted with polyclonal anti-
-human adiponectin or leptin antibody in a conjugation with 
a horseradish peroxidase enzyme in a microtitre plate well.
Statistical analysis
Data are expressed as number, percent, mean ± standard 
deviation (SD). Unpaired and paired Student’s t-test was 
used to evaluate differences between the two groups. For all 
the tests, a two-tailed p ≤ 0.05 was considered statistically 
significant. All calculations were made using Excel 2003 
program for Windows.
Results
Table 1 shows the characteristics of patients with ischaemic 
heart disease enrolled in this study. The mean age was 
56.7 years. About one-third of patients have a previous 
ischaemic heart disease.
The current ECG findings of myocardial ischaemia 
were present in 44.1% of the patients (Table 1). Left ven-
tricle hypokinesia and left ventricular hypertrophy were 
observed in 10.1% (Table 1). Coronary CT investigation 
explored, that 30.5% of patients had a positive calcium 
score and 67.8% of patients did not show evidence of 
coronary changes by CT angiography (Table 1). At the time 
of entry into the study, the means systolic and diastolic 
blood pressures of the patients were within the normal 
range (Table 2). The mean systolic and diastolic blood 
pressures were 136.6 and 84.7mmHg, respectively. Sy-
stolic and diastolic blood pressure of ≥ 140 mm Hg and 
≥ 90 mm Hg was observed in 29 (49.2%) and 26 (44.1%) 
patients respectively. The results of anthropometric me-
asurements revealed, that the patients were overweight 
by the evidence of that the value of the mean body 
mass index was 28.93 ± 3.3 kg/m2 (Table 2). The waist 
circumference of ≥ 102 cm was observed in 39 (66.1%) 
of patients and the mean value was 103.1 cm. The mean 
waist/hip and waist to height ratios exceeded normal 
limits, and their means were 0.98 and 0.627 respectively 
(Table 2). The mean value of fasting serum triglyceride 
was 180 mg/dL, which is higher than the critical level 
of 150 mg/dL. Fifty-six of the patients had a serum 
triglyceride level above 150 mg/dL. The mean value of 
serum high-density lipoprotein was 46.8 mg/dL; 24 out 
Table 1. Characteristics of the study
Variables Values
Gender (male:female) 24:35
Age (years) 56.7 ± 8.0
Previous history of ischaemic heart disease 18 (30.5)
ECG findings (ischaemia) (positive) 26 (44.1)
Echocardiograph findings:
• ejection fraction 69.5 ± 3.3
• hypokinesia of left ventricle 6 (10.2)
• left ventricular hypertrophy 6 (10.2)
Coronary computed tomography:
• calcium coronary score (positive) 18 (30.5)
• angiography (negative) 40 (67.8)
The results expressed as a number (percentage), and mean ± standard deviation; ECG — electro-
cardiograph
Table 2. Cardio-metabolic risk factors
Variables Determinant values
Blood pressure measurement [mm Hg]
Systolic 136.6 ± 16.6
Diastolic 84.7 ± 7.6
Pulse pressure 51.9 ± 10.7
Mean arterial 102 ± 10.2
Anthropometric measurements
Body mass index [kg/m2] 28.93 ± 3.3
• < 25 7 (11.9)
• ≥ 25 52 (88.1)
Waist [cm] 103.13 ± 7.63
• ≥ 102 39 (66.1)
Hip [cm] 105.4 ± 8.64
Waist/hip ratio 0.98 ± 0.046
Waist/height ratio 0.627 ± 0.037
Fasting serum lipid profile [mg/dL]
Triglycerides [mg/dL] 180.6 ± 33.9
• ≥ 150 56 (94.9)
Cholesterol [mg/dL] 182.1 ± 36.8
High-density lipoprotein [mg/dL] 46.8 ± 5.5
• ≤ 35 (men) or ≤ 50 (women) 24 (40.7)
Low-density lipoprotein [mg/dL] 99.2 ± 36.9
Very-low-density lipoprotein [mg/dL] 36.1 ± 6.8
Atherogenic index 0.583 ± 0.102
The results expressed as mean ± standard deviation and number (percentage)
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of 35 women had a level ≤ 50 mg/dL. The atherogenic 
index, that represents the log (triglyceride/high-density 
lipoprotein ratio) was higher than the cut-off ratio and was 
equal to 0.583. The data of coronary CT revealed, that 
there is a variation in calcium score, and seven patients 
had a calcium score ranged between 372–595 Agatstone 
(Table 3). Eleven patients had a critical lesion in the left 
anterior descending coronary artery with a positive CT 
angiogram. Five patients with critical lesions in corona-
ry arteries had a negative result of calcium score, that 
is, zero. The serum leptin levels of the patients were 
significantly higher (p < 0.001) than healthy subjects 
(1329.9 ± 754.5 ng/mL vs 140.2 ± 26.2 ng/mL, respecti-
vely), while the serum adiponectin levels were significan-
tly (p < 0.001) less than corresponding levels of healthy 
controls (0.039 ± 0.030 ng/ml vs 0.2 ± 0.01 ng/mL, 
respectively) (Table 4). The serum leptin levels were signi-
ficantly low in patients with a positive calcium score and 
angiogram coronary CT, compared with those who had no 
abnormalities in coronary CT. Further analysis revealed 
a significant positive correlation between body mass index 
with serum leptin (r = 0.296, p < 0.02), and non-significant 
negative correlation with adiponectin (r = –0.1, p > 0.05). 
An inverse significant correlation was found between 
the log atherogenic index with serum leptin (r = –0.354, 
p < 0.01), but it did not correlate with serum adiponec-
tin. Moreover, a significant positive correlation between 
ejection fraction percentage with serum leptin (r = 0.285, 
p < 0.05), and a non-significant correlation with serum 
adiponectin (r = 0.155, p > 0.05) were observed.
Discussion
The results of this study showed significant paradoxical 
alterations of serum leptin levels, and non-significant 
changes in serum adiponectin levels in patients with 
ischaemic heart disease. Cardio-metabolic risk factors in 
terms of overweight-obesity and abnormal lipid profile (high 
fasting serum triglycerides and low high-density lipoprotein) 
were detected in considerable percent and in agreement 
with other studies [19, 20]. The data of coronary calcium 
score revealed, that 18 patients were at risk of future 
myocardial infarction. Yamamoto et al. [21] reported, that 
the cardiovascular disease mortality is significantly higher 
among patients who had a CAC score ≥ 100 than among 
those with a CAC score < 100, that means nine patients 
of our study were at high risk. The mean values of blood 
pressure measurement were within the normal values and 
possibly not influenced the present results with adiponectin 
and leptin as dysregulation of adipokines levels is asso-
ciated with resistant hypertension [22]. The pattern of the 
atherogenic lipid profile is commonly observed in patients 
with coronary artery disease. High percentage of patients 
are obese, and they are at risk of cardiovascular disease, 
therefore, obesity may influence the adipokines levels, as 
the serum leptin levels are increased while adiponectin 
levels are decreased in obesity [23, 24]. Significant positive 
correlation between serum leptin levels and BMI highlights 
the importance of serum leptin levels as an indicator of 
cardio-metabolic risk factors. In addition, low serum leptin 
levels in patients with negative coronary CT compared with 
those with positive data indicated, that leptin per se is not 
involved in coronary atherosclerosis or in the plaque insta-
bility [25]. The non-significant inverse correlation between 
serum adiponectin levels and body mass index besides the 
non-significant differences in adiponectin levels between 
Table 3. The results of coronary calcium score and angiogram
Variables Measurements
Calcium score (Agatstone)
No score 41 (69.5)
1–50 4 (6.8)
51–100 5 (8.5)
101–200 1 (1.7)
201–300 1 (1.7)
> 301 7 (11.9)
CT angiogram (critical lesion)
One vessel
Left anterior descending 11 (18.6)
Left circumflex 2 (3.4)
Right 1 (1.7)
Two vessels 4 (6.8)
Three vessels 1 (1.7)
The results expressed as a number (percentage)
Table 4. Serum levels of leptin and adiponectin
Variables Serum adiponec-
tin [ng/mL]
Serum leptin 
[ng/mL]
Minimum–maximum 34.4–2625.3 0–0.164
Median 1329.9 0.031
Mean ± SD 1329.9 ± 754.5 0.039 ± 0.030
Coronary CT
Negative calcium score 1630 ± 639.6 0.041 ± 0.027
Positive calcium score 670.8 ± 626.9* 0.037 ± 0.037
Coronary angiogram
Negative angiogram 1786.9 ± 523.3 0.038 ± 0.028
Positive angiogram 443.5 ± 255.8* 0.041 ± 0.035
The results are expressed as mean ± standard deviation (SD); *compared with corresponding 
negative data; CT — computed tomography
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patients with positive and negative CT do not agree with 
another study, that demonstrated that low levels of total 
or high-molecular-weight adiponectin levels are associated 
with the calcified or non-calcified coronary plaque [26]. 
The other important result is the significant correlation 
between serum leptin levels and the left ventricular ejection 
fraction, that indicated the serum leptin might serve as 
a predictor of cardiac function [17]. Therefore, this study 
is an attempt to provide further data in the above topic and 
is worth attention.
Conclusions
We conclude, that high serum leptin levels impact a fa-
vourable effect upon the patients with ischaemic heart 
disease, as it was associated with negative coronary CT 
and improvement in left ventricular function.
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Streszczenie
Wstęp. Adiponektyna jest adipocytokiną, białkiem produkowanym przez tkankę tłuszczową, natomiast leptyna jest biał-
kiem przyczyniającym się u ludzi do utrzymania masy ciała przez wpływ na przysadkę mózgową. Hormony te oddziałują 
na siebie na różnych poziomach czynników ryzyka sercowo-naczyniowego. Badanie przeprowadzono w celu oceny stężeń 
adiponektyny i leptyny w surowicy pacjentów z niedokrwienną chorobą serca, których poddano koronarografii i u których 
określono wskaźnik uwapnienia tętnic (CCS).
Materiał i metody. Do badania włączono 59 pacjentów z chorobą niedokrwienną serca i 20 zdrowych osób tworzących 
grupę kontrolną. U chorych wykonano badania elektrokardiograficzne, echokardiograficzne, koronarografię i tomografię 
tętnic wieńcowych (CCT) w celu oceny CCS. Surowicze stężenia adiponektyny i leptyny oznaczono metodą immunoen-
zymatyczną (ELISA).
Wyniki. W ocenie uwapnienia tętnic, dokonanej za pomocą tomografii komputerowej (CT) tętnic wieńcowych, u 30,5% 
chorych uzyskano wynik dodatni, a u 67,8% chorych nie stwierdzono zmian w tętnicach wieńcowych w angiografii CT. 
U osób z chorobą niedokrwienną stężenia leptyny były istotnie wyższe, a adiponektyny — niższe niż w grupie kontrolnej. 
U chorych z dodatnim CCS i zmianami w angiogramie stężenie leptyny w surowicy było istotnie niższe niż u osób bez 
nieprawidłowości w CCT. Stwierdzono istotną dodatnią korelację frakcji wyrzutowej ze stężeniem leptyny w surowicy 
(r = 0,285; p < 0,05) oraz nieistotną korelację ze stężeniem adiponektyny w surowicy.
Wnioski. Surowicze stężenia leptyny i adiponektyny są użytecznymi wskaźnikami u pacjentów z chorobą niedokrwienną 
serca, ponieważ wysokie stężenie leptyny wiązało się z ujemnym wynikiem CCT i korelowało dodatnio z frakcją wyrzutową 
lewej komory.
Słowa kluczowe: leptyna, adiponektyna, wskaźnik uwapnienia tętnic wieńcowych
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